MedTrace Logo

Evaluation of POC Pulse-dose Demand Oxygen Delivery for Nocturnal Hypoxemia

NCT06000332 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-01-05

No results posted yet for this study

Summary

The aim of this study is to describe the effect of the Inogen Rove 6 Portable Oxygen Concentrator on peripheral oxygen saturation in adults receiving supplemental oxygen at night and examine whether the device can adequately maintain oxygen saturation during sleep.

Conditions

  • Nocturnal Hypoxemia

Interventions

DEVICE

InogenOne Rove 6 Portable Oxygen Concentrator

overnight use of Portable Oxygen Concentrator, 6 hours minimum

Sponsors & Collaborators

  • Inogen Inc.

    lead INDUSTRY

Principal Investigators

  • Stanislav Glezer, MD · Inogen Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-17
Primary Completion
2023-12-21
Completion
2023-12-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06000332 on ClinicalTrials.gov